178 related articles for article (PubMed ID: 7625808)
1. Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
Clemons KV; Homola ME; Stevens DA
Antimicrob Agents Chemother; 1995 May; 39(5):1169-72. PubMed ID: 7625808
[TBL] [Abstract][Full Text] [Related]
2. Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.
Lutz JE; Clemons KV; Aristizabal BH; Stevens DA
Antimicrob Agents Chemother; 1997 Jul; 41(7):1558-61. PubMed ID: 9210684
[TBL] [Abstract][Full Text] [Related]
3. Efficacies of two novel azole derivatives each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis.
Clemons KV; Stevens DA
Antimicrob Agents Chemother; 1997 Jan; 41(1):200-3. PubMed ID: 8980782
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo activities of posaconazole against Coccidioides immitis.
González GM; Tijerina R; Najvar LK; Bocanegra R; Rinaldi M; Loebenberg D; Graybill JR
Antimicrob Agents Chemother; 2002 May; 46(5):1352-6. PubMed ID: 11959568
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fluconazole and SDZ89-485 for therapy of experimental murine coccidioidomycosis.
Fierer J; Kirkland T; Finley F
Antimicrob Agents Chemother; 1990 Jan; 34(1):13-6. PubMed ID: 2327748
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis.
Clemons KV; Hanson LH; Perlman AM; Stevens DA
Antimicrob Agents Chemother; 1990 May; 34(5):928-30. PubMed ID: 2360832
[TBL] [Abstract][Full Text] [Related]
7. Large-Scale Evaluation of
Thompson GR; Barker BM; Wiederhold NP
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096163
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.
Pappagianis D; Zimmer BL; Theodoropoulos G; Plempel M; Hector RF
Antimicrob Agents Chemother; 1990 Jun; 34(6):1132-8. PubMed ID: 2393272
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
Sugar AM; Liu XP
Antimicrob Agents Chemother; 1996 May; 40(5):1314-6. PubMed ID: 8723494
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole treatment of nonmeningeal coccidioidomycosis in children: two case reports and review of the literature.
Homans JD; Spencer L
Pediatr Infect Dis J; 2010 Jan; 29(1):65-7. PubMed ID: 19884875
[TBL] [Abstract][Full Text] [Related]
11. Current Concepts and Future Directions in the Pharmacology and Treatment of Coccidioidomycosis.
Thompson GR; Lewis JS; Nix DE; Patterson TF
Med Mycol; 2019 Feb; 57(Supplement_1):S76-S84. PubMed ID: 30690601
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.
Connolly P; Wheat J; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
Antimicrob Agents Chemother; 1999 Feb; 43(2):322-8. PubMed ID: 9925526
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.
Tucker RM; Denning DW; Arathoon EG; Rinaldi MG; Stevens DA
J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):593-601. PubMed ID: 2170479
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
Hata K; Kimura J; Miki H; Toyosawa T; Nakamura T; Katsu K
Antimicrob Agents Chemother; 1996 Oct; 40(10):2237-42. PubMed ID: 8891121
[TBL] [Abstract][Full Text] [Related]
15. [A case of coccidioidomycosis in Turkey imported from the United States of America].
Başaran S; Karabıçak N; Şimşek Yavuz S; Wiederhold NP; Şafak S; Sarıbuğa A; Sutton DA; Bingöl Z; Çağatay A; Özsüt H; Kılıçaslan Z; Eraksoy H
Mikrobiyol Bul; 2017 Apr; 51(2):183-190. PubMed ID: 28566083
[TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas.
Ramani R; Chaturvedi V
Mycopathologia; 2007 Jun; 163(6):315-9. PubMed ID: 17484074
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
Li RK; Ciblak MA; Nordoff N; Pasarell L; Warnock DW; McGinnis MR
Antimicrob Agents Chemother; 2000 Jun; 44(6):1734-6. PubMed ID: 10817743
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.
Kobayashi GS; Travis SJ; Rinaldi MG; Medoff G
Antimicrob Agents Chemother; 1990 Apr; 34(4):524-8. PubMed ID: 2344160
[TBL] [Abstract][Full Text] [Related]
19. In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Cordeiro Rde A; Brilhante RS; Rocha MF; Medrano DJ; Monteiro AJ; Tavares JL; de Lima RA; de Camargo ZP; Sidrim JJ
Int J Antimicrob Agents; 2009 Sep; 34(3):278-80. PubMed ID: 19520551
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
Oakley KL; Morrissey G; Denning DW
Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
